Summary
Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
Market Segment as follows:
By Type
500 mg
150 mg
By Application
Breast Cancer
Colorectal cancer
Stomach Cancer
By Company
Teva
Roche
Mylan
Hikma
Hengrui Medicine
Cipla
Reliance Group
Hetero
The main contents of the report including:
Section 1:
Product definition, type and application, global and China market overview;
Section 2:
Global and China Market competition by company;
Section 3:
Global and China sales revenue, volume and price by type;
Section 4:
Global and China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Summary:
Get latest Market Research Reports on Capecitabine. Industry analysis & Market Report on Capecitabine is a syndicated market report, published as Global and China Capecitabine Market Research by Company, Type & Application 2013-2025. It is complete Research Study and Industry Analysis of Capecitabine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.